The National Genomic Test Directory specifies which genomic tests are commissioned by the NHS in England and the patients who are eligible to access to each test.
The Test Directory (opens in a new tab) is hosted on the NHS England website.
The Clinical Indications, tests available and eligibility criteria for patients are regularly updated. A major update to the Solid Tumour Test Directory is published each year in Spring. Minor updates are published throughout the year.
Please review this information and the NHSE published documents to ensure you are aware of any updates that may affect your practice.
Update: 20th September 2023
| Clinical Indication Test Code | Clinical Indication | |
|---|---|---|
| Clinical Indication Test Code M1.4 | Clinical Indication Colorectal carcinoma |
Known colorectal carcinoma, when MMR IHC not possible / not performed, as per NICE Guidelines algorithm for molecular testing for Lynch syndrome. Please refer to Rare & Inherited disease directory R210 Lynch syndrome for full eligibility criteria.
Known colorectal carcinoma, when MMR IHC not possible / not performed, as per NICE Guidelines for molecular testing to inform therapy choice. Delivery via pathology in some regions.